Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study


In a population prevalence-based modelling study, Alessandro Cassini and colleagues estimate the burden of six healthcare-associated infections on European population health in disability-adjusted life years.


Vyšlo v časopise: Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. PLoS Med 13(10): e32767. doi:10.1371/journal.pmed.1002150
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1002150

Souhrn

In a population prevalence-based modelling study, Alessandro Cassini and colleagues estimate the burden of six healthcare-associated infections on European population health in disability-adjusted life years.


Zdroje

1. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011; 32: 101–114. doi: 10.1086/657912 21460463

2. World Health Organization (WHO). Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO; 2011. http://apps.who.int/iris/bitstream/10665/80135/1/9789241501507_eng.pdf.

3. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014; 370: 1198–1208. doi: 10.1056/NEJMoa1306801 24670166

4. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012; 17(46). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20316. 23171822

5. European Centre for Disease prevention and Control. Annual epidemiological report on communicable diseases in Europe 2008 Stockholm: ECDC; 2009. http://ecdc.europa.eu/en/publications/Publications/0812_SUR_Annual_Epidemiological_Report_2008.pdf.

6. European Centre for Disease prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013. http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf.

7. Muray CJL, Salomon JA, Marthers CD, Lopez AD. Summary measures of population health. Geneva: WHO; 2002. http://apps.who.int/iris/bitstream/10665/42439/1/9241545518.pdf.

8. Sherman ER, Heydon KH, St John KH, Teszner E, Rettig SL, Alexander SK, et al. Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol. 2006; 27: 332–337. doi: 10.1086/502684 16622808

9. Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A, Muhlberger N, et al. The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases. PLoS ONE. 2013; 8: e79740. doi: 10.1371/journal.pone.0079740 24278167

10. Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM, Longhi S, et al. New methodology for estimating the burden of infectious diseases in Europe. PLoS Med. 2012; 9: e1001205. doi: 10.1371/journal.pmed.1001205 22529750

11. European Centre for Disease prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals—protocol version 4.3. Stockholm: ECDC; 2012. http://ecdc.europa.eu/en/publications/Publications/0512-TED-PPS-HAI-antimicrobial-use-protocol.pdf.

12. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012; 380: 2063–2066. doi: 10.1016/S0140-6736(12)61899-6 23245602

13. Haagsma JA, Polinder S, Cassini A, Colzani E, Havelaar AH. Review of disability weight studies: comparison of methodological choices and values. Popul Health Metr. 2014; 12: 20. doi: 10.1186/s12963-014-0020-2 26019690

14. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015; 3: e712–723. doi: 10.1016/S2214-109X(15)00069-8 26475018

15. Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, et al. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr. 2015; 13: 1–15. doi: 10.1186/s12963-015-0042-4 26778920

16. Haller S, Deindl P, Cassini A, Suetens C, Zingg W, Abu Sin M, et al. Neurological sequelae of healthcare-associated sepsis in very-low-birthweight infants: Umbrella review and evidence-based outcome tree. Euro Surveill. 2016 Feb 25; 21(8). doi: 10.2807/1560-7917.ES.2016.21.8.30143 http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21389. 26940884

17. Robert Koch Institute. Burden of healthcare associated infection (BHAI)—evidence-based and comorbidity-adjusted outcome trees for estimation of burden of disease. Berlin: RKI; 2016. http://www.rki.de/DE/Content/Institut/OrgEinheiten/Abt3/FG37/Research_Report_BHAI.pdf?__blob=publicationFile.

18. European Centre for Disease prevention and Control. ECDC BCoDE toolkit [software application]. Stockholm: European Centre for Disease Prevention and Control; 2015. version 1.4: http://ecdc.europa.eu/en/healthtopics/burden_of_communicable_diseases/Pages/Tool.aspx.

19. McCabe WR. Gram-Negative Bacteremia. Arch Intern Med. 1962; 110: 847. doi: 10.1001/archinte.1962.03620240029006

20. Astagneau P, Rioux C, Golliot F, Brucker G, Group INS. Morbidity and mortality associated with surgical site infections: results from the 1997–1999 INCISO surveillance. J Hosp Infect. 2001; 48: 267–274. doi: 10.1053/jhin.2001.1003 11461127

21. Eurostat. Hospital beds by type of care. 2013. http://ec.europa.eu/eurostat/web/health/health-care/data/database.

22. Eurostat. Hospital discharges by diagnosis, in-patients, per 100 000 inhabitants. 2011. http://ec.europa.eu/eurostat/web/health/health-care/data/database.

23. Rhame FS, Sudderth WD. Incidence and prevalence as used in the analysis of the occurrence of nosocomial infections. Am J Epidemiol. 1981; 113: 1–11. 7457475

24. Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014; 14: 147. doi: 10.1186/1471-2458-14-147 24517715

25. Vose D Risk analysis—a quantitative guide. Chichester: John Wiley & Sons, LTD.; 2001.

26. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal. 2013. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781

27. Colzani E. Results from the 2015 Burden of Communicable Diseases in Europe (BCoDE) study. European Public Health Conference; Milan, 2015.

28. Global Burden of Disease Study. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386: 743–800. doi: 10.1016/S0140-6736(15)60692-4 26063472

29. Kwong JC, Ratnasingham S, Campitelli MA, Daneman N, Deeks SL, Manuel DG, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS ONE. 2012; 7: e44103. doi: 10.1371/journal.pone.0044103 22962601

30. Thomas C, Stevenson M, Williamson DJ, Riley TV. Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy. Clin Infect Dis. 2002; 35: 1457–1462. doi: 10.1086/342691 12471563

31. Suetens C. Healthcare-associated infections in European long-term care facilities: how big is the challenge? Euro Surveill. 2012; 17(35). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20259. 22958606

32. Clec'h C, Schwebel C, Francais A, Toledano D, Fosse JP, Garrouste-Orgeas M, et al. Does catheter-associated urinary tract infection increase mortality in critically ill patients? Infect Control Hosp Epidemiol. 2007; 28: 1367–1373. doi: 10.1086/523279 17994517

33. Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care. 2002; 17: 50–57. 12040549

34. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000; 28: 68–75. doi: 10.1016/S0196-6553(00)90015-4 10679141

35. Gastmeier P, Brauer H, Sohr D, Geffers C, Forster DH, Daschner F, et al. Converting incidence and prevalence data of nosocomial infections: results from eight hospitals. Infect Control Hosp Epidemiol. 2001; 22: 31–34. doi: 10.1086/501821 11198019

36. Berthelot P, Garnier M, Fascia P, Guyomarch S, Jospe R, Lucht F, et al. Conversion of prevalence survey data on nosocomial infections to incidence estimates: a simplified tool for surveillance? Infect Control Hosp Epidemiol. 2007; 28: 633–636. doi: 10.1086/513536 17464932

37. Rossello-Urgell J, Rodriguez-Pla A. Behavior of cross-sectional surveys in the hospital setting: a simulation model. Infect Control Hosp Epidemiol. 2005; 26: 362–368. doi: 10.1086/502553 15865272

38. European Centre for Disease prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf.

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2016 Číslo 10
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa